Jose is a seasoned biotech commercial leader with deep expertise in value and access, strategic pricing, reimbursement, new product development and global commercialization. He successfully built and led market access, pricing and reimbursement functions at three leading biopharma companies, with in-depth experience in gene therapy and rare diseases. Jose previously led the global market access and global strategic marketing functions at AveXis. Prior to AveXis, he worked at Shire Pharmaceuticals, Abbott Laboratories and Eli Lilly. While at Shire, Jose led global market access for the rare diseases business, including the lysosomal disorders commercial and pipeline products.